coronary atherosclerosis
Showing 1 - 25 of 60
Mitophagy in Myeloid Cells During Coronary Atherosclerosis.
Not yet recruiting
- Coronary Atherosclerosis
- Blood samples
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Jan 23, 2023
Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)
Not yet recruiting
- Coronary Artery Disease
- +2 more
- heated tobacco - lifestyle intervention
-
Warsaw, PolandNational Institute of Cardiology
Dec 27, 2022
Coronary Disease, Coronary Artery Disease, Coronary Atherosclerosis Trial in Annecy, Grenoble (MGuard stent, Drug eluting stent
Completed
- Coronary Disease
- +3 more
- MGuard stent
- Drug eluting stent and bare metal stent
-
Annecy, France
- +1 more
May 18, 2022
Coronary Atherosclerosis, Coronary Artery Disease, Contrast-induced Nephropathy Trial in Tallinn, Amsterdam, Moscow (Coronary
Suspended
- Coronary Atherosclerosis
- +6 more
- Coronary computed tomography angiography
- Quantitative coronary angiography, intravascular imaging with percutaneous intervention
-
Tallinn, Estonia
- +3 more
Mar 12, 2022
Coronary Atherosclerosis Trial in Nanjing (aspirin 100 mg/d, indobufen 200 mg bid)
Recruiting
- Coronary Atherosclerosis
- aspirin 100 mg/d
- indobufen 200 mg bid
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Jan 18, 2022
Hypertension, Coronary Atherosclerosis Trial in Tokyo (Calcium channel blockers (amlodipine, azelnidipine))
Completed
- Hypertension
- Coronary Atherosclerosis
- Calcium channel blockers (amlodipine, azelnidipine)
-
Tokyo, JapanDepartment of Cardiology, Juntendo University School of Medicine
May 12, 2021
Coronary Atherosclerosis Trial in Suita (continuous glucose monitoring (CGM))
Unknown status
- Coronary Atherosclerosis
- continuous glucose monitoring (CGM)
-
Suita, JapanNational Cerebral & Cardiovascular Center
Sep 19, 2020
Coronary Artery Disease, Coronary Restenosis, Coronary Atherosclerosis Trial in France, Germany (Agent Paclitaxel-coated
Completed
- Coronary Artery Disease
- +3 more
- Agent Paclitaxel-coated balloon
- SeQuent® Please Paclitaxel-coated Balloon
-
Lyon, France
- +11 more
Dec 20, 2019
Type 2 Diabetes, Coronary Atherosclerosis Trial in Seoul (iobitridol, gadoterate meglumine)
Completed
- Type 2 Diabetes Mellitus
- Coronary Atherosclerosis
- iobitridol
- gadoterate meglumine
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 14, 2019
Coronary Atherosclerosis, Endothelial Dysfunction, Coronary Small Vessel Disease Trial in Rochester (LipiScan/LipiScan IVUS)
Completed
- Coronary Atherosclerosis
- +2 more
- LipiScan/LipiScan IVUS
-
Rochester, MinnesotaMayo Clinic
Mar 1, 2019
Acute Coronary Syndrome, Coronary Atherosclerosis, Angina, Unstable Trial in Kelowna, Vancouver, Victoria (Fractional Flow
Terminated
- Acute Coronary Syndrome
- +2 more
- Fractional Flow Reserve (FFR)
-
Kelowna, British Columbia, Canada
- +3 more
Feb 25, 2019
Coronary Atherosclerosis Trial in United States
Withdrawn
- Coronary Atherosclerosis
-
Gainesville, Florida
- +4 more
Jan 16, 2019
Coronary Atherosclerosis, Angina Pectoris, Myocardial Infarction Trial in Norway (Percutaneous coronary intervention (PCI))
Completed
- Coronary Atherosclerosis
- +2 more
- Percutaneous coronary intervention (PCI)
-
Arendal, Norway
- +7 more
Dec 20, 2018
Trial on Vascular Inflammation in Atopic Dermatitis
Completed
- Atopic Dermatitis
- +2 more
- FDG-PET Scan
- +2 more
-
Montreal, Quebec, CanadaInnovaderm Research Inc
Dec 17, 2018
Myocardial Ischemia in Non-obstructive Coronary Artery Disease
Completed
- Coronary Atherosclerosis
- Myocardial Ischemia
-
Bergen, NorwayDepartment of Heart Disease, Haukeland University Hospital
Nov 5, 2018
Ischemic Heart Disease, Coronary Artery Disease, Coronary Atherosclerosis Trial in Novosibirsk (SYNERGY 48 mm, PCI, 3 month OCT
Unknown status
- Ischemic Heart Disease
- +2 more
- SYNERGY 48 mm
- +3 more
-
Novosibirsk, Russian FederationAcademician E.N. Meshalkin national medical research center
Jan 15, 2018
Ischemic Heart Disease, Coronary Atherosclerosis, Coronary Artery Disease Trial in Novosibirsk (DES "Calypso", DES "Xience
Completed
- Ischemic Heart Disease
- +3 more
- DES "Calypso"
- +2 more
-
Novosibirsk, Russian FederationState Research Institute of CIrculation Pathology
Dec 14, 2017
Adipokines of Epicardial Adipose Tissue and Atherosclerosis of
Unknown status
- Coronary Atherosclerosis
- Adipokines
-
Ioánnina, GreeceUniversity Hospital of Ioannina
Oct 23, 2017
Coronary Atherosclerosis Trial in Nanjing (aspirin 100mg/d therapy, aspirin 100mg/2d therapy, aspirin 100mg/3d therapy)
Unknown status
- Coronary Atherosclerosis
- aspirin 100mg/d therapy
- +6 more
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Jul 27, 2017
Coronary Atherosclerosis, Myocardial Infarction, Coronary Plaque Embolization Trial in United States (Embolic Protection Device
Terminated
- Coronary Atherosclerosis
- +2 more
- Embolic Protection Device (EPD)
- +2 more
-
Scottsdale, Arizona
- +8 more
Jun 8, 2017
DNA Damage & Repair Proteins In Atherosclerotic Coronary Artery
Completed
- Coronary Atherosclerosis
-
Chertsey, Surrey, United Kingdom
- +1 more
Feb 21, 2017
Myocardial Perfusion Heterogeneity in Normal SPECT Studies
Completed
- Coronary Artery Disease
- Coronary Atherosclerosis
- semi conductor gamma camera
-
Grenoble, Isere, FranceChu Grenoble
Jan 2, 2017
Coronary Atherosclerosis, Endothelial Dysfunction, Coronary Small Vessel Disease Trial in Rochester (Optical Coherence
Completed
- Coronary Atherosclerosis
- +2 more
- Optical Coherence Tomography (C7 XR Dragonfly )
-
Rochester, MinnesotaMayo Clinic
Sep 30, 2016
Psoriasis, Vascular Inflammation, Coronary Atherosclerosis Trial in Canada (Adalimumab, Placebo)
Completed
- Psoriasis
- +2 more
- Adalimumab
- Placebo
-
Markham, Ontario, Canada
- +4 more
Sep 8, 2016
Ischemic Heart Disease, Coronary Atherosclerosis, Coronary Artery Disease Trial in Novosibirsk (CTO coronary angioplasty,
Completed
- Ischemic Heart Disease
- +3 more
- CTO coronary angioplasty
- +2 more
-
Novosibirsk, Russian FederationState Research Institute of CIrculation Pathology
May 15, 2016